ConductScience.org, home

Paper87477

Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Parham P and 2 others. J Immunol, 1979. Cited by 710 papers, by iCite.

Cite this record

ConductScience Library. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. Papers, record 87477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/87477

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.
PubMed
Journal
J Immunol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
710
iCite
Relative citation ratio, by iCite
14.4
iCite
Revised in PubMed
2020-12-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parham PP
2Barnstable CJC J
3Bodmer WFW F

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
HLA AntigensMajor topic
Animals
Binding Sites, Antibody
Chemical Phenomena
Chemistry
Chromosome Mapping
Clone Cells
Epitopes
Genetic Code
Humans
Mice
Papain
beta 2-Microglobulin

Source PubMed

Download CSV of topics

Cited by235

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 710 citations.

PMIDTitleJournalYearIn PapersSource
42929886Cytokine-Mediated Plasticity in the Molecular Requirements for Peptide-Loading Complex Formation and Antigen Presentation.Cells2026https://conductscience.org/library/papers/42929886PubMed
41734996Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition.J Immunother Cancer2026https://conductscience.org/library/papers/41734996PubMed
40872797SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression.Viruses2025https://conductscience.org/library/papers/40872797PubMed
40749828Molecular characterization of the archaic HLA-B∗73:01 allele reveals presentation of a unique peptidome and skewed engagement by KIR2DL2.J Biol Chem2025https://conductscience.org/library/papers/40749828PubMed
39476840An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania.Cell2024https://conductscience.org/library/papers/39476840PubMed
39057057Conformational Alterations of the Cell Surface of Monomeric and Dimeric β2m-Free HLA-I (Proto-HLA) May Enable Novel Immune Functions in Health and Disease.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39057057PubMed
38939414Characterising the HLA-I immunopeptidome of plasma-derived extracellular vesicles in patients with melanoma.J Extracell Biol2024https://conductscience.org/library/papers/38939414PubMed
38900146Multimodal HLA-I genotype regulation by human cytomegalovirus US10 and resulting surface patterning.Elife2024https://conductscience.org/library/papers/38900146PubMed
38733995Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules.Structure2024https://conductscience.org/library/papers/38733995PubMed
38596688Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes.Front Immunol2024https://conductscience.org/library/papers/38596688PubMed
38542184Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells.Int J Mol Sci2024https://conductscience.org/library/papers/38542184PubMed
37773139Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer's disease.Cell Biosci2023https://conductscience.org/library/papers/37773139PubMed
37737643Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.J Immunol2023https://conductscience.org/library/papers/37737643PubMed
37674626Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma.Mol Ther Oncolytics2023https://conductscience.org/library/papers/37674626PubMed
37207206Effects of HLA single chain trimer design on peptide presentation and stability.Front Immunol2023https://conductscience.org/library/papers/37207206PubMed
36165200Cross-Talk between HLA Class I and TLR4 Mediates P-Selectin Surface Expression and Monocyte Capture to Human Endothelial Cells.J Immunol2022https://conductscience.org/library/papers/36165200PubMed
36134954Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.Antibodies (Basel)2022https://conductscience.org/library/papers/36134954PubMed
36010968Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy.Cancers (Basel)2022https://conductscience.org/library/papers/36010968PubMed
35318648Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles.Immunology2022https://conductscience.org/library/papers/35318648PubMed
35303241Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor.Immunol Res2022https://conductscience.org/library/papers/35303241PubMed

See all 235 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-B3106PubTator's text mininghttps://conductscience.org/library/genes/3106NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/87477

GET https://conductscience.org/api/papers/v1/87477/cited_by?page=2